Latest debt-to-equity ratio
BioNexus Gene Lab Debt-to-equity ratio
Direct answer
BioNexus Gene Lab's debt-to-equity ratio is 4.16%.
The verified market snapshot reports 4.16%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 12, 2026.
Get free BioNexus Gene Lab email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 4.16%
Explore related company data
View BioNexus Gene Lab's market capitalizationView BioNexus Gene Lab's price-to-book ratioView BioNexus Gene Lab's return on equityView BioNexus Gene Lab's 52-week price rangeView BioNexus Gene Lab's revenue growthView BioNexus Gene Lab's profit marginView all BioNexus Gene Lab key metricsReturn to BioNexus Gene Lab profile